140 related articles for article (PubMed ID: 3454344)
1. Antihormone-steroid hormonal activity, heat-shock protein hsp 90 and receptors.
Baulieu EE
Horm Res; 1987; 28(2-4):181-95. PubMed ID: 3454344
[TBL] [Abstract][Full Text] [Related]
2. Steroid hormone antagonists at the receptor level: a role for the heat-shock protein MW 90,000 (hsp 90).
Baulieu EE
J Cell Biochem; 1987 Oct; 35(2):161-74. PubMed ID: 3323207
[TBL] [Abstract][Full Text] [Related]
3. RU486 (an anti-steroid hormone) receptor structure and heat shock protein mol. wt 90,000 (hsp 90).
Baulieu EE
Hum Reprod; 1988 May; 3(4):541-7. PubMed ID: 3292573
[TBL] [Abstract][Full Text] [Related]
4. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.
Groyer A; Schweizer-Groyer G; Cadepond F; Mariller M; Baulieu EE
Nature; 1987 Aug 13-19; 328(6131):624-6. PubMed ID: 3614365
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of antisteroid hormones at the receptor level.
Baulieu EE
Kidney Int Suppl; 1988 Oct; 26():S2-7. PubMed ID: 3059030
[No Abstract] [Full Text] [Related]
6. Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU 486-glucocorticosteroid receptor complexes display agonist activity.
Schweizer-Groyer G; Cadepond F; Groyer A; Idziorek T; Mariller M; Baulieu EE
J Steroid Biochem; 1988; 30(1-6):291-4. PubMed ID: 3386256
[TBL] [Abstract][Full Text] [Related]
7. Receptor-associated nuclear proteins and steroid/antisteroid action.
Baulieu EE; Binart N; Cadepond F; Catelli MG; Chambraud B; Garnier J; Gasc JM; Groyer-Schweizer G; Oblin ME; Radanyi C
Ann N Y Acad Sci; 1990; 595():300-15. PubMed ID: 2197969
[No Abstract] [Full Text] [Related]
8. [Receptor mechanisms of glucocorticoid and antiglucocorticoid effects].
Golikov PP
Vopr Med Khim; 1996; 42(3):184-92. PubMed ID: 9139449
[TBL] [Abstract][Full Text] [Related]
9. Effects of steroid hormones and antihormones in cultured cells.
Jung-Testas I; Baulieu EE
Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
[TBL] [Abstract][Full Text] [Related]
10. [Antagonist and agonist effects of the antiprogesterone RU 486].
Schaison G
Ann Endocrinol (Paris); 1989; 50(3):200-7. PubMed ID: 2683974
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of transcriptional activation by steroid hormone receptors.
Baniahmad A; Tsai MJ
J Cell Biochem; 1993 Feb; 51(2):151-6. PubMed ID: 8440749
[TBL] [Abstract][Full Text] [Related]
12. Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor.
Svec F
Endocrinology; 1988 Oct; 123(4):1902-6. PubMed ID: 3416819
[TBL] [Abstract][Full Text] [Related]
13. Are receptor-associated nuclear proteins associated with the earliest effects of steroid hormones?
Baulieu EE; Binart N; Cadepond F; Catelli MG; Chambraud B; Garnier J; Gasc JM; Groyer-Schweizer G; Rafestin-Oblin ME; Radanyi C
Symp Soc Exp Biol; 1990; 44():3-20. PubMed ID: 2130517
[TBL] [Abstract][Full Text] [Related]
14. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.
Bourgeois S; Pfahl M; Baulieu EE
EMBO J; 1984 Apr; 3(4):751-5. PubMed ID: 6327286
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins.
Tumlin JA; Lea JP; Swanson CE; Smith CL; Edge SS; Someren JS
J Clin Invest; 1997 Mar; 99(6):1217-23. PubMed ID: 9077529
[TBL] [Abstract][Full Text] [Related]
16. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
Ratka A; Sutanto W; Bloemers M; de Kloet ER
Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
18. 11 beta-substituted steroids, an original pathway to antihormones.
Teutsch G; Ojasoo T; Raynaud JP
J Steroid Biochem; 1988 Oct; 31(4B):549-65. PubMed ID: 3059056
[TBL] [Abstract][Full Text] [Related]
19. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Gaillard RC; Herrmann W
Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor.
Jung-Testas I; Baulieu EE
Exp Cell Res; 1983 Aug; 147(1):177-82. PubMed ID: 6617759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
